Introduction
In chronic kidney disease (CKD), the risk for premature death, primarily as a result of cardiovascular disease, is high and this risk increases early on in kidney failure [1, 2] . Traditional risk factors insufficiently predict cardiovascular outcome in CKD; less traditional risk factors, like inflammation, endothelial dysfunction, oxidative stress, vascular calcification and malnutrition, seem to play an at least as important role [3] [4] [5] [6] . When renal function deteriorates, a number of substances, normally excreted in the urine, are retained within the body. In 2003, a list of 90 known uraemic compounds was published and several of these have the potential to induce vascular damage [7] . However, further identification of unknown compounds and the elucidation of pathophysiological mechanisms remain necessary to better understand the process of vessel damage in CKD and to develop specific therapeutic interventions [8] [9] [10] .
The dinucleoside polyphosphates (Np n N) are a newly identified group of compounds only recently added to the list of uraemic retention solutes [11] . Np n N contain two nucleosides interconnected by a variable number of phosphates; with a molecular weight between 800 and 1200 Da, they belong to the so-called middle molecules (molecular structures: see Figure 1 ) [12] .
Specific members of this group have been detected in human plasma, platelets, neuronal cells, endothelial cells, adrenal glands and myocardial tissue [13] [14] [15] [16] . In haemodialysis patients, the intracellular diadenosine polyphosphates (Ap n A) are increased in platelets and released upon activation [17] . Also, renal tubular cells release Ap 5 A, Ap 6 A and uridine adenosine tetraphosphate (Up 4 A), and Up 4 A is released by the endothelium as well [18] .
The Np n N play a role in vasoregulation, neurotransmission and cell signalling [19] [20] [21] . Related to the cardiovascular system, Np n N have been shown to interfere with the function of thrombocytes, endothelium and smooth muscle cells [16, 19, [22] [23] [24] . Despite the fact that leucocytes are also key mediators in vessel damage, studies of Np n N with these cells are scarce and fragmentary, both regarding the type of cell and the Np n N variant. Leucocytes play an important role in the immune response. CKD is considered as a state of chronic inflammation characterized by a dual immune response; on one hand, many CKD patients have a baseline status of inflammation, while on the other hand, their immune function upon stimulation is often suppressed, resulting in an increased susceptibility to infection [5, 25] .
The present study investigates the biological impact of a series of Np n N on leucocyte function to evaluate their contribution to the uraemic syndrome. Chronic inflammation in CKD is associated with oxidative stress and, since leucocytes are an important source of reactive oxygen species (ROS) [26, 27] , the effect of the Np n N was evaluated by measuring changes in leucocyte oxidative burst activity. The effect of the number of phosphate groups on leucocyte oxidative burst activity was studied by testing Ap 3 A to Ap 6 A, the subgroup of Np n N on which the most extensive information is available. Since the most pronounced effects in this analysis were found for Ap 4 
Materials and methods

Reagents
High-pressure liquid chromatography (HPLC) water (gradient grade) and acetonitrile (ACN) were purchased from Merck (Darmstadt, Germany); all other substances were obtained from Sigma-Aldrich (Munich, Germany), unless otherwise specified.
Synthesis of Np n N
The Np n N tested in vitro were Ap 3 A, Ap 4 A, Ap 5 A, Ap 6 A, Ap 4 G, Gp 4 G and Up 4 A. They were all synthesized following a protocol described by Ng and Orgel [28] and chromatographed according to a method by Jankowski et al. [29] .
Briefly, depending on the type of Np n N, adenosine 5′-polyphosphates, guanosine 5′-polyphosphates and/or uridine 5′-monophosphate were dissolved in water together with N-[2-hydroxyethyl]-piperazine-N′-2-ethanesulfonic acid, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide and MgCl 2 and incubated at 37°C for 48 h at pH 6.5.
Np n N were concentrated on a C18 reversed-phase column (Supersphere 100 C18 endcapped, 100 × 2; 1 mm, 4 μm, 10 nm, Merck, Germany) using 40 mM aqueous triethylammonium acetate and were eluted with 30% ACN in water. The lyophilized concentrate of the reversedphase column was injected on two C18 reversed-phase columns connected in series (Supersphere, 300 × 8 mm, 4 μm, Merck, Germany) and was chromatographed in the displacement mode by use of n-butanol (100 mM). The fractions containing Np n N of the displacement chromatography were lyophilized and each fraction was chromatographed with an anion exchange column (column: UnoQ (Biorad), 100 × 10 μm, 10 μm; eluent A, 20 mM K 2 HPO 4 ; eluent B, 20 mM K 2 HPO 4 and 1 M NaCl; gradient: 0-10 min, 0-5% B; 10-115 min, 5-40% B; and 115-120 min, 40-100% B; flow rate, 1.0 mL/min; and UV absorption wavelength, 254 nm). The fractions of the anion exchange chromatography were desalted by HPLC reversed-phase C18 chromatography. The chromatographically isolated Np n N were lyophilized and stored at −20°C [29] .
Sample collection
The present protocol was approved by the local ethics committee after informed consent. Heparinized whole blood from healthy donors, not smoking and not taking any medication, was collected. Additionally, heparinized whole blood was taken from haemodialysis patients prior to the dialysis session.
In vitro effect of dinucleoside polyphosphates on the leucocyte oxidative burst Experimental set-up. The present study was performed according to a standardized protocol for in vitro testing of uraemic retention solutes described by Cohen et al. [30] , generated after ample discussion among the experts of the European Uraemic Toxin (EUTox) Work Group. This monograph recommends testing the highest reported uraemic concentration. It is of note, however, that current data on Np n N concentrations are still limited. Up till now, only Jankowski et al. described an increased intracellular amount of Ap n A in platelets and an increased release by platelets of haemodialysis patients upon activation. A maximum release of 154 ± 59 fg Ap 4 A/platelet (range from 95 to 213 fg Ap 4 A/platelet) was described [17] and, since whole blood contains 4 × 10 5 platelets/μl, we calculated a mean local concentration of 61.6 ng Ap4A/μl blood (range from 38.0 to 85.2 ng Ap 4 A/μl blood) or 72.2 μM (range from 45.4 to 101.9 μM). In the in vitro set-up, therefore, a concentration of 100 μM was tested for each Np n N which, based upon the current knowledge, rather reflects local concentrations of Np n N after release from their storage cells than their plasma concentration. These values also correspond to the local concentrations reported by Ogilvie [31] .
The lyophilized Np n N were resuspended separately in saline (0.9% NaCl, Baxter) in a 10-fold concentrated stock solution of 1 mM and stored at −20°C and, upon testing, they were diluted 1:10 in heparinized whole blood.
Oxidative burst. To evaluate the effect of the Np n N on the production of ROS in leucocytes, the Bursttest (Phagoburst®) (Orpegen Pharma, Heidelberg, Germany) was applied after a 10-min incubation period at 37°C in the presence of the separate Np n N, as described previously [32] .
The oxidative burst activity of the leucocytes was measured at baseline, after moderate stimulation with N-formyl-methionine-leucinephenylalanine (fMLP, 0.83 μM) and after strong stimulation with phorbol 12-myristate 13-acetate (PMA, 1.35 μM). Samples were analysed with the FACScan® flow cytometer (Becton Dickinson). Experiments were repeated eight (Ap n A) or six (Np 4 N) times.
FACScan analysis. Using the CellQuest Pro™ software, 10 000 events were counted in every sample. Based on their light scatter properties, monocytes, granulocytes and lymphocytes were gated separately. Within these gates, the percentage of rhodamine-positive cells (%) was evaluated for the baseline and fMLP-stimulated samples. The mean fluorescence intensity (MFI) per cell was considered as a measure for the oxidative burst activity after PMA stimulation.
Endotoxin concentration
To exclude that an effect due to lipopolysaccharide (LPS) contamination was observed, all experimental solutions causing a stimulation of the oxidative burst were checked by means of the Limulus Amebocyte Lysate (LAL) QCL-1000 test, a quantitative kinetic and chromogenic assay (Cambrex Bio Science, Walkersville, MD, USA). The detection limit of this assay is 0.005 endotoxin units (EU)/mL.
Statistical analysis
Data are expressed as the mean ± SEM. Normality was checked with the Kolmogorov-Smirnov test in combination with descriptive statistics. Statistics were performed using a paired t-test for the in vitro data. A P-value of <0.05 was considered significant.
Results
Effect of a varying number of phosphate groups on the leucocyte oxidative burst activity Effects of Np n N with a varying number of phosphate groups linking the two nucleoside moieties are described. To evaluate whether the number of phosphate groups plays a role in the effect of the Np n N on leucocyte oxidative burst activity, four Ap n A with three to six phosphate groups were tested.
At baseline, 4.65 ± 0.10% of the monocytes, 4.76 ± 0.07% of the granulocytes and 2.63 ± 0.53% of the lymphocytes (n = 8) produced ROS. As presented in Figure 2A , incubation with Ap 4 A and Ap 5 A induced a significant rise (P < 0.05, n = 8) in free radical production in all three leucocyte types. For both monocytes and lymphocytes also, Ap 6 A resulted in a significantly increased percentage of rhodamine-positive cells. Finally, for Ap 3 A, no significant effects were observed.
A moderate stimulation of the Bursttest with fMLP resulted in a significant increase of the ROS production for monocytes and granulocytes in the saline condition as well as in the presence of Ap n A. However, only Ap 6 A affected the fMLP-induced ROS production in comparison to the saline condition in monocytes. The oxidative burst in lymphocytes remained unaffected by fMLP as previously demonstrated and the Ap n A showed an enhanced activity versus saline which was comparable with the effects observed in baseline cells ( Figure 2B ) [33] .
After stimulation with PMA, 97.1 ± 1.51% of the leucocytes produced ROS and, therefore, the MFI was evaluated for these samples. As demonstrated in Figure 2C , Ap 4 A further enhanced the oxidative burst activity in monocytes, while Ap 6 A inhibited it in granulocytes. The most significant effects were seen in the lymphocytes where Ap 3 A, Ap 4 A and Ap 5 A significantly enhanced free radical production.
The present data demonstrate that, depending on the number of phosphate groups and the type of leucocyte, Ap n A has a different impact on the oxidative burst activity at baseline and after stimulation. In general, they have a leucocyte-activating impact even in combination with another activator. This effect is most prominent in lymphocytes.
Effect of varying the type of nucleoside
Based on the previous results, the number of phosphate groups was maintained constant at four in the second series of experiments, and the effect of the type of nucleosides on the oxidative burst response was studied by testing Ap 4 A, Ap 4 G, Gp 4 G and Up 4 A. Figure 3A represents the oxidative burst activity at baseline (A) for monocytes, granulocytes and lymphocytes. Compared to Ap 4 A, which was stimulatory for all cell types, for Ap 4 G and Up 4 A, a stimulatory effect was ob-served in monocytes, while Ap 4 G and Gp 4 G both inhibited the ROS production in granulocytes.
The monocytic fMLP-stimulated oxidative burst activity was enhanced in the presence of Up 4 A, while no effects on the fMLP-stimulated Bursttest in granulocytes were seen. None of the compounds with four phosphate groups, except for Ap 4 A, showed an effect on lymphocytes, neither at baseline nor after fMLP stimulation ( Figure 3B ).
As shown in Figure 3C , Up 4 A caused, in parallel with Ap 4 A, a significant rise in free radical production in PMAstimulated monocytes and lymphocytes. No effect was seen on the PMA-stimulated granulocytes or after incubation with Ap 4 G and Gp 4 G.
By studying the effect of different types of nucleosides (Np 4 N), it can be concluded that, again, different effects are observed in the different types of leucocytes under study. The most important effects are observed in the presence of Up 4 A, especially in monocytes and with Ap 4 A in lymphocytes. However, after PMA stimulation, Up 4 A induces a significantly higher response compared to Ap 4 A in both cell types.
Effect of the combination Ap 4 A and Up 4 A
Because of their most prominent effects, the effect on leucocyte ROS production of a combination of Ap 4 A and Up 4 A was evaluated (each at 100 μM). Although the above-described results were confirmed in blood from healthy donors, no cumulative effect of the compounds could be demonstrated (data not shown).
In contrast, when the Ap 4 A and Up 4 A mixture was added to whole blood obtained from haemodialysis patients, collected just before the start of haemodialysis, no significant effects on the ROS production could be observed (data not shown).
Endotoxin concentration
All solutions tested were checked for their endotoxin concentration by performing the LAL test. None of them had a LPS concentration above 0.05 EU/mL, which corresponds to 4 pg LPS/mL, except for Ap 6 A containing 0.26 EU/mL.
When testing LPS in the Bursttest at this concentration, no effect was observed however. Therefore, it can be ex- Fig. 2 . Effect of the Ap n A (n = 3-6) on the oxidative burst activity of monocytes, granulocytes and lymphocytes at baseline (A) and after fMLP stimulation (B), expressed as %, and after PMA stimulation, expressed as MFI (*P < 0.05, **P < 0.01 versus saline; n = 8).
cluded that the effects observed are attributable to endotoxin contamination.
Discussion
The present study evaluated the role of the Np n N as newly identified uraemic retention solutes in CKD-related inflammation and atherogenesis. To the best of our knowledge, it is the first time that the impact of different Np n N on oxidative burst activity of several types of leucocytes was tested, at baseline as well as after stimulation. The effect of the number of phosphate groups was studied in the most studied subgroup of Np n N, the Ap n A (n = 3-6). Based upon the results, the effect of the type of nucleoside was studied on Np n N with four phosphate groups but a varying type of nucleoside, i.e. Ap 4 A, Ap 4 G, Gp 4 G and Up 4 A. Also, the effect of a combination of Ap 4 A and Up 4 A was tested.
Mainly, a pro-inflammatory effect of the Np n N on leucocytes was found. Depending on the number of phosphate groups, lymphocytes were especially susceptible to the Ap n A, with Ap 4 A inducing a marked stimulation of the oxidative burst activity in cells at baseline, but also after fMLP and after PMA stimulation (Figure 2) . Considering the type of nucleoside, Up 4 A was shown to exert the most significant stimulatory effects on the basal and fMLP-activated monocytes ( Figure 3A and B) and after PMA stimulation in both monocytes and lymphocytes ( Figure 3C) . A combination of both Ap 4 A and Up 4 A revealed a comparable, but not a cumulative, effect on ROS production by normal leucocytes, whereas on uraemic leucocytes, no effect on ROS production could be observed.
Oxidative stress plays an important negative role in the cardiovascular outcome of the CKD patient and oxidative stress is present already in the early stages of CKD [27, 34] . The present study illustrates that Np n N, especially the ones containing four phosphate groups, may contribute to this pro-inflammatory status.
Also, the type of nucleoside can be at the origin of diverse effects, as is described for vasoconstriction of arteries where Fig. 3 . Effect of the Np4N on the oxidative burst activity of monocytes, granulocytes and lymphocytes at baseline (A) and after fMLP stimulation (B), expressed as %, and after PMA stimulation, expressed as MFI (*P < 0.05 versus saline; n = 6).
one adenine seemed crucial and sufficient because of the equipotent effect of Ap n A and Ap n G, whereas in contrast, Gp n G were inactive [24] . In the present study, it was shown that the presences of adenosines and uridines have a stimulatory effect on lymphocytes and monocytes, whereas guanosines have an inhibitory effect on granulocytes.
The observation that an increase of Np n N in an extreme uraemic milieu does not induce additional ROS production by uraemic leucocytes, as was observed for normal leucocytes, leads to the assumption that the effects observed with healthy donor blood mirrors the importance of their effect in the early stages of CKD playing a role in the initial phase of the atherosclerotic process.
The observed inhibitory effect in the presence of Ap 6 A and the G-containing Np n N can be related to the enhanced susceptibility of the CKD patient for infection [25] . Opposite effects related to the phosphate chain length in the Np n N have already been previously demonstrated in vasoactivity or platelet aggregation [24, 35] .
The specificity of the nucleosides for the different leucocyte subpopulations is most probably due to variability in their purinergic P2 receptor expression patterns for Np n N. There are two main families of P2 receptors, P2X and P2Y. P2X receptors form plasma membrane channels selective for monovalent and divalent ions and do not require intracellular messengers. P2Y, on the other hand, are G protein-coupled receptors and, upon activation, inositol 1,4,5-triphosphate is generated and intracellular Ca 2+ is released, followed by a Ca 2+ influx from outside the cell [36] . Each of these receptors has a series of subtypes and, as recently reviewed in haematopoietic cell lines, many of them are present in leucocytes [37] . Next, a series of interactions of adenosine triphosphate (ATP) and adenosine diphosphate (ADP) with P2Y receptors on leucocytes were described during vascular injury [38] . The type of P2 receptors playing a role in the currently observed effects on ROS production can differ among the type of Np n N tested, the cell type and the stimulus. The use of inhibitors like suramin, a P2 purinergic antagonist, α,β-methylene ATP, a P2X1 inhibitor or other selective antagonists should elucidate this in the future.
Data on the effects of Np n N on leucocytes had been, up to now, limited to the evaluation of the effect of some Ap n A in neutrophils. It was found that Ap 3 A and Ap 4 A are able to prime the respiratory burst if followed by further fMLP stimulation in isolated neutrophils and this effect was Ca 2+ -dependent with Np n N concentrations above 50 μM. The priming effects appeared to be maximal when the Ap n A were added 1 min before fMLP and at 600-800 μM [39] . The same group also found that Ap n A (n = 3-6) delayed neutrophil apoptosis [40, 41] . They also suggested that neutrophils express P2 receptors with different binding affinities to mononucleotides and dinucleotides [42] . Vartanian et al. found that interferons induce an accumulation of Ap 3 A in both a monocytic and a granulocytic human cell line due to an accumulation of the enzyme tryptophanyl-tRNA synthetase [43] .
According to the standardized protocol for in vitro testing of uraemic retention solutes developed by the EUTox Work Group, the Np n N were tested at their highest estimated uraemic concentration [30] . Considering the still limited available data on concentrations of NpnN in CKD, the Np n N concentration was based upon the release of Ap n A by thrombocytes from haemodialysis patients [17] . Np n N are released by endothelial cells and platelets, which are both cell types playing a role in atherogenesis. Hence, it is likely that, intravascularly, leucocytes are locally exposed to similar Np n N concentrations especially if the producing cells are activated, as is the case for thrombocytes and endothelium in uraemia [44] .
The present data were obtained by performing acute experiments with an exposure time of only 10 min. In vivo, the chronic exposure in CKD is, however, continuous, especially in atherosclerotic lesions, which contain macrophages, lymphocytes as well as thrombocytes, and thus the damaging impact is conceivably more persistent [26] . Of note, another possibility that should be considered is that the damaging effect of Np n N in vivo is attenuated by compensatory, regulatory and/or repairing mechanisms. Although such mechanisms are certainly at play, it should be taken into account that the net in vivo result of these interactions is still essentially pro-inflammatory.
The definition/specification of Np n N as uraemic retention solutes is mainly based on the following observations: Np n N are endogenous compounds with a strong impact on physiologic and pathophysiologic processes in the cardiovascular system [21, 22, 45] ; Np n N are released by different cell types involved in atherosclerosis, the major cause of death in CKD (e.g. thrombocytes, endothelial cells) [15, 18] ; platelets from haemodialysis patients have an increased intracellular Ap n A concentration and an increased release [17] ; Up 4 A plasma concentration is increased in juvenile hypertensives versus normotensives and Up 4 A is described to affect glomerular filtration rate [22, 45] . Uraemic plasma concentrations per se have, however, been rarely reported. The quantification of Np n N in CKD (Stage 2-5) and in uraemic patients before and after haemodialysis is currently under investigation in different ongoing studies. Based upon the increased release of Ap n A from platelets from haemodialysis patients [17] , local concentrations of Np n N were calculated to rise up to 100 μM.
Based on their molecular weight ranging from 800 to 1200 Da, the Np n N are classified as middle molecules. In addition, dinucleosides were shown to be protein bound [13] . Because of their physicochemical characteristics, Np n N are expected to be difficult to remove by dialysis, bringing along the need for more advanced removal strategies such as online haemodiafiltration, adsorption and/or pharmaceutical interventions in the function of the involved pathophysiological mechanism [10, 12] .
Conclusion
In conclusion, this study describes, for the first time, the effect of a series of Np n N on leucocyte oxidative burst activity in relation to uraemia. Depending on the length of the phosphate chain, the type of nucleoside and the type of leucocyte, a different impact on the oxidative burst activity at baseline and after stimulation was observed. In general, these data, especially showing a pro-inflammatory effect, suggest that Np n N are likely to be involved in the development of atherosclerosis, probably in the early stages of CKD.
